 ifaonline.co.uk | NICE draft "yes" for MabThera, "no" to Gilenya Pharma Times Evidence shows that adding MabThera to chemotherapy treatments cyclophosphamide, vincristine and prednisolone (CVP), cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP), mitoxantrone, chlorambucil and prednisolone (MCP) and ... NICE Expands Chemotherapy Options with Rituximab |
